MECURE Share Price Performance
₦27.70
14.75 (113.90%)
130.8% overvalued intrinsic discount
₦12.00
Fair Value
Price ₦27.70
Wane_Investment_House ₦12.00
Fair Value₦12.00
Share Pricen/a
Mecure Industries PLC Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
MECURE Community Narratives
WA
Fair Value ₦12 130.8% overvalued intrinsic discount
MeCure Industries Plc Q2 Result
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
MeCure Industries Plc Q2 Result
MeCure Industries Plc has delivered exceptional growth in Q2 2025, highlighted by a 634% YoY surge in pre-tax profit and 165% revenue growth , driven primarily by booming demand in its acute care and OTC product segments. The company’s sharp revenue and margin expansion have firmly placed it on an upward profitability trajectory.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
WA
₦12
130.8% overvalued intrinsic discount
Wane_Investment_House Fair Value
Revenue growth
N/A
Profit Margin
14.66%
Future PE
24.99x
Share price in 2028
₦0
Snowflake Analysis
Mecure Industries PLC Key Details
About MECURE
- Founded
- 2005
- Employees
- n/a
- CEO
- WebsiteView website
Mecure Industries PLC manufactures and sells pharmaceuticals and nutraceuticals in Nigeria. The company develops, produces, and markets generic drugs, as well as specialty pharmaceuticals. It offers tablets, capsules and syrups; and multivitamins and dietary supplements. The company was incorporated 2005 and is based in Lagos, Nigeria.